Skip to content

VERIPHARM

Active
Public limited companyfounded 2001active for 25 yearsSt.-Jozefslaan 55, 2400 Mol, BelgiumKBO/BCE: BE 0475.905.160
Summary

VERIPHARM has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €885,230 and a net result of €184,855, of which €164,087 non-recurring income. Equity is growing by about 3.1% per year across the filed financial years. Its solvency ranks better than 63% of 2,802 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
VERIPHARMActiveChecked score 95/100
Risk analysis ReportCompare

History

VERIPHARM was incorporated on 19 October 2001.1 Total assets fell from €2.1m in 2018 to €1.5m in 2025 and headcount from 1.6 full-time equivalents in 2018 to 2.3 in 2020.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018, 2020 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
02-07
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial Highest result from 2018 to 2025net €184,855 ▲411%
Net result €184,855, the highest in the series.
31-12
Financial Liquidity more than quadruplescurrent ratio 5.00
Current ratio from 1.07 to 5.00; short-term debt falls from €639,952 to €68,058.
01-08
Gazette deed Reappointments: Verté Rita (afgevaardigd bestuurder) and Verelst Louis (director)
4 facts ▸
  • General meeting, 25-06-2025
  • Director reappointment, Verté Rita (afgevaardigd bestuurder)
  • Director reappointment, Verelst Louis (director)
  • Other provision, “einde mandaat huidige bestuurders, na de algemene vergadering d.d. 2025-06-25” (deed in Dutch)
01-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
01-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
22-12
Gazette deed Amendment of the articles
Capital2 facts ▸
  • Amendment of the articles (2 times)
  • Capital, €261,500
01-07
NBB filing Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial Weakest financial yearnet €18,013 ▼82.3%
Net result drops to €18,013, the lowest in the series; recovery starts the following year.
28-06
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
2021
31-12
Financial Liquidity doublescurrent ratio 5.68
Current ratio from 2.77 to 5.68; short-term debt falls from €311,930 to €135,306.
29-06
NBB filing Annual accounts filed
financial year 2020 · abbreviated format
Show earlier events
2020
31-12
Financial Equity above €1mequity €1.1m ▲12.9%
A profit in every financial year since 2018 builds equity to €1.1m.
01-07
NBB filing Annual accounts filed
financial year 2019 · abbreviated format
2019
27-06
NBB filing Annual accounts filed
financial year 2018 · abbreviated format
2018
09-07
NBB filing Annual accounts filed
financial year 2017 · abbreviated format
2017
30-06
NBB filing Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 25 annual accounts filed, the latest 10 are here; all 25 are under Financials.
2 of 5 deeds read
About the unread acts

Of the 5 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure